Psychiatry Research: Neuroimaging
Volume 182, Issue 1 , Pages 40-47 , 30 April 2010

Improving 1H MRSI measurement of cerebral lactate for clinical applications

  • Neva M. Corrigan

      Affiliations

    • Department of Radiology, University of Washington, Seattle, WA, USA
    • Corresponding Author InformationCorresponding author. Neuroimaging Research Group, Department of Radiology, University of Washington, 1100 NE 45th St. Suite 555, Seattle, WA, 98105, USA. Tel.: +1 206 685 8404; fax: +1 206 616 7791.
  • ,
  • Todd L. Richards

      Affiliations

    • Department of Radiology, University of Washington, Seattle, WA, USA
  • ,
  • Seth D. Friedman

      Affiliations

    • Seattle Children's Hospital, Seattle, WA, USA
  • ,
  • Helen Petropoulos

      Affiliations

    • Department of Radiology, University of Washington, Seattle, WA, USA
  • ,
  • Stephen R. Dager

      Affiliations

    • Department of Radiology, University of Washington, Seattle, WA, USA

Received 14 August 2009 ,Revised 10 November 2009 ,Accepted 16 November 2009.

References 

  1. Barker PB, Soher BJ, Blackband SJ, Chatham JC, Mathews VP, Bryan RN. Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference. NMR in Biomedicine. 1993;6:89–94
  2. Behar KL, den Hollander JA, Stromski ME, Ogino T, Shulman RG, Petroff OA, et al. High-resolution 1H nuclear magnetic resonance study of cerebral hypoxia in vivo. Proceedings of the National Academy of Sciences of the United States of America. 1983;80:4945–4948
  3. Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D. Cramer–Rao bounds: an evaluation tool for quantitation. NMR in Biomedicine. 2001;14:278–283
  4. Dager SR, Marro KI, Richards TL, Metzger GD. Preliminary application of magnetic resonance spectroscopy to investigate lactate-induced panic. American Journal of Psychiatry. 1994;151:57–63
  5. Dager SR, Friedman SD, Heide A, Layton ME, Richards T, Artru A, et al. Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactate-induced panic. Archives of General Psychiatry. 1999;56:70–77
  6. Dager SR, Layton ME, Strauss W, Richards TL, Heide A, Friedman SD, et al. Human brain metabolic response to caffeine and the effects of tolerance. American Journal of Psychiatry. 1999;156:229–237
  7. Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK, et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Archives of General Psychiatry. 2004;61:450–458
  8. Dager SR, Corrigan NM, Richards TL, Posse S. Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Topics in Magnetic Resonance Imaging. 2008;19:81–96
  9. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magnetic Resonance in Medicine. 1989;11:47–63
  10. Frahm J, Kruger G, Merboldt KD, Kleinschmidt A. Dynamic uncoupling and recoupling of perfusion and oxidative metabolism during focal brain activation in man. Magnetic Resonance in Medicine. 1996;35:143–148
  11. Friedman SD, Shaw DW, Artru AA, Dawson G, Petropoulos H, Dager SR. Gray and white matter brain chemistry in young children with autism. Archives of General Psychiatry. 2006;63:786–794
  12. Friedman SD, Shaw DW, Artru AA, Richards TL, Gardner J, Dawson G, et al. Regional brain chemical alterations in young children with autism spectrum disorder. Neurology. 2003;60:100–107
  13. Friedman SD, Jensen JE, Frederick BB, Artru AA, Renshaw PF, Dager SR. Brain changes to hypocapnia using rapidly interleaved phosphorus-proton magnetic resonance spectroscopy at 4T. Journal of Cerebral Blood Flow and Metabolism. 2007;27:646–653
  14. Gu M, Kim DH, Mayer D, Sullivan EV, Pfefferbaum A, Spielman DM. Reproducibility study of whole-brain 1H spectroscopic imaging with automated quantification. Magnetic Resonance in Medicine. 2008;60:542–547
  15. Guillemaud R. Uniformity correction with homomorphic filtering on region of interest. IEEE ICIP. 1998;2:872–875
  16. Jackson EF, Doyle TJ, Wolinsky JS, Narayana PA. Short TE hydrogen-1 spectroscopic MR imaging of normal human brain: reproducibility studies. Journal of Magnetic Resonance Imaging. 1994;4:545–551
  17. Jiru F, Skoch A, Klose U, Grodd W, Hajek M. Error images for spectroscopic imaging by LCModel using Cramer–Rao bounds. MAGMA. 2006;19:1–14
  18. Kanowski M, Kaufmann J, Braun J, Bernarding J, Tempelmann C. Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES. Magnetic Resonance in Medicine. 2004;51:904–912
  19. Kaufmann P, Shungu DC, Sano MC, Jhung S, Engelstad K, Mitsis E, et al. Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology. 2004;62:1297–1302
  20. Kreis R. Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts. NMR in Biomedicine. 2004;17:361–381
  21. Kreis R, Boesch C. Bad spectra can be better than good spectra. In: Proceedings of the 11th Meeting of the International Society of Magnetic Resonance in Medicine, Toronto, USA. 2003;p. 264
  22. Li BS, Babb JS, Soher BJ, Maudsley AA, Gonen O. Reproducibility of 3D proton spectroscopy in the human brain. Magnetic Resonance in Medicine. 2002;47:439–446
  23. Lin DD, Crawford TO, Barker PB. Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR. American Journal of Neuroradiology. 2003;24:33–41
  24. Macri MA, Garreffa G, Giove F, Guardati M, Ambrosini A, Colonnese C, et al. In vivo quantitative 1H MRS of cerebellum and evaluation of quantitation reproducibility by simulation of different levels of noise and spectral resolution. Magnetic Resonance Imaging. 2004;22:1385–1393
  25. Maddock RJ. The lactic acid response to alkalosis in panic disorder: an integrative review. Journal of Neuropsychiatry and Clinical Neurosciences. 2001;13:22–34
  26. Makoroff KL, Cecil KM, Care M, Ball WS. Elevated lactate as an early marker of brain injury in inflicted traumatic brain injury. Pediatric Radiology. 2005;35:668–676
  27. Mathews VP, Barker PB, Blackband SJ, Chatham JC, Bryan RN. Cerebral metabolites in patients with acute and subacute strokes: concentrations determined by quantitative proton MR spectroscopy. AJR. American Journal of Roentgenology. 1995;165:633–638
  28. Maudsley AA, Darkazanli A, Alger JR, Hall LO, Schuff N, Studholme C, et al. Comprehensive processing, display and analysis for in vivo MR spectroscopic imaging. NMR in Biomedicine. 2006;19:492–503
  29. Otazo R, Mueller B, Ugurbil K, Wald L, Posse S. Signal-to-noise ratio and spectral linewidth improvements between 1.5 and 7 Tesla in proton echo-planar spectroscopic imaging. Magnetic Resonance in Medicine. 2006;56:1200–1210
  30. Posse S, Dager SR, Richards TL, Yuan C, Ogg R, Artru AA, et al. In vivo measurement of regional brain metabolic response to hyperventilation using magnetic resonance: proton echo planar spectroscopic imaging (PEPSI). Magnetic Resonance in Medicine. 1997;37:858–865
  31. Posse S, Otazo R, Caprihan A, Bustillo J, Chen H, Henry PG, et al. Proton echo-planar spectroscopic imaging of J-coupled resonances in human brain at 3 and 4 Tesla. Magnetic Resonance in Medicine. 2007;58:236–244
  32. Prichard J, Rothman D, Novotny E, Petroff O, Kuwabara T, Avison M, et al. Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation. Proceedings of the National Academy of Sciences of the United States of America. 1991;88:5829–5831
  33. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine. 1993;30:672–679
  34. Sappey-Marinier D, Calabrese G, Fein G, Hugg JW, Biggins C, Weiner MW. Effect of photic stimulation on human visual cortex lactate and phosphates using 1H and 31P magnetic resonance spectroscopy. Journal of Cerebral Blood Flow and Metabolism. 1992;12:584–592
  35. Schurr A. Lactate: the ultimate cerebral oxidative energy substrate?. Journal of Cerebral Blood Flow and Metabolism. 2006;26:142–152
  36. Sijens PE, Levendag PC, Vecht CJ, van Dijk P, Oudkerk M. 1H MR spectroscopy detection of lipids and lactate in metastatic brain tumors. NMR in Biomedicine. 1996;9:65–71
  37. Sijens PE, Smit GP, Rodiger LA, van Spronsen FJ, Oudkerk M, Rodenburg RJ, et al. MR spectroscopy of the brain in Leigh syndrome. Brain and Development. 2008;30:579–583
  38. Tedeschi G, Bertolino A, Righini A, Campbell G, Raman R, Duyn JH, et al. Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging. Neurology. 1995;45:1384–1391
  39. Tedeschi G, Bertolino A, Campbell G, Barnett AS, Duyn JH, Jacob PK, et al. Reproducibility of proton MR spectroscopic imaging findings. AJNR. American Journal of Neuroradiology. 1996;17:1871–1879
  40. Tkac I, Ugurbil K, Gruetter R. On the quantification of low concentration metabolites by 1H NMR spectroscopy in the human brain at 7 Tesla. In: Proceedings of the 10th Meeting of the International Society of Magnetic Resonance in Medicine, Honolulu, USA. 2002;p. 528
  41. van Rijen PC, Luyten PR, van der Sprenkel JW, Kraaier V, van Huffelen AC, Tulleken CA, et al. 1H and 31P NMR measurement of cerebral lactate, high-energy phosphate levels, and pH in humans during voluntary hyperventilation: associated EEG, capnographic, and Doppler findings. Magnetic Resonance in Medicine. 1989;10:182–193

PII: S0925-4927(09)00276-5

doi: 10.1016/j.pscychresns.2009.11.007

Psychiatry Research: Neuroimaging
Volume 182, Issue 1 , Pages 40-47 , 30 April 2010